Periodic Therapeutic Phlebotomy Mitigates Systemic Aging Phenotypes by Promoting Bone Marrow Function.

Periodic therapeutic phlebotomy improved aging-associated behavioral deficits and neurogenesis in D-galactose-induced aging models.

• The study used D-galactose-induced aging models to evaluate the effects of periodic therapeutic phlebotomy.
• Behavioral deficits associated with aging showed notable improvement following the phlebotomy intervention.
• Neurogenesis was also significantly improved as part of the comprehensive anti-aging effects observed.

Periodic therapeutic phlebotomy significantly decreased circulating senescence-associated secretory phenotype (SASP) levels.

• A significant decrease in the level of circulating senescence-associated secretory phenotypes was observed following periodic therapeutic phlebotomy.
• This reduction in SASP markers is consistent with a systemic mitigation of the aging phenotype.
• The decrease in SASPs was part of a comprehensive anti-aging response documented across multiple organ systems.

Periodic therapeutic phlebotomy mitigated aging-associated structural degradation and molecular alterations across multiple organ systems.

• Improvements were observed in muscle, bone, liver, kidney, and nervous systems.
• Both structural degradation and molecular alterations within these organs were obviously mitigated.
• The breadth of organ-level improvements indicates systemic rather than tissue-specific anti-aging effects.

The mechanistic basis of phlebotomy-induced anti-aging effects involves restoration of the bone marrow microenvironment through functional rescue of mesenchymal stem cells and endothelial cells.

• Periodic therapeutic phlebotomy induced bone marrow microenvironment restoration.
• The restoration was mediated through functional rescue of mesenchymal stem cells and endothelial cells within the bone marrow.
• This microenvironmental restoration reestablished balanced hematopoietic homeostasis.

Hematopoietic revitalization driven by bone marrow restoration subsequently led to systemic improvements in peripheral blood composition and function.

• Reestablishment of hematopoietic homeostasis was linked to downstream improvements in peripheral blood.
• Both peripheral blood composition and function were improved following the hematopoietic revitalization.
• This mechanism mirrors aspects of heterochronic parabiosis but without requiring a plasma donor source.

Periodic therapeutic phlebotomy was identified as a technically simple and safe strategy with potential for clinical translation as an anti-aging intervention.

• The study highlights 'technical simplicity and safety profile' as advantages of the phlebotomy strategy.
• Unlike heterochronic parabiosis, phlebotomy does not depend on limited plasma sources, which 'greatly affects clinical translation' of blood exchange approaches.
• The authors state the strategy 'will hold potential to pave the way for clinical translation.'